| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9204064 | Surgical Neurology | 2005 | 5 Pages |
Abstract
Enterobacter meningitis is an infrequent complication of neurological insult. Treatment is often complicated by resistance of Enterobacter species to third-generation cephalosporins. Our results indicate that while third-generation cephalosporins are not the most appropriate choice of agents to treat Enterobacter meningitis, TMP-SMX may yield satisfactory results.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
David R. PharmD, Denise H. PharmD,